1.
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC)
by Woodward, Mark
Heart (British Cardiac Society), 2007-02, Vol.93 (2), p.172-176

2.
A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity
by Marshall, Nichola J
Hypertension (Dallas, Tex. 1979), 2013-01, Vol.61 (1), p.246-252

3.
Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12, A1BG, and the Selectin Region and Cardiovascular Outcomes
by McDonough, Caitrin W
Hypertension (Dallas, Tex. 1979), 2013-07, Vol.62 (1), p.48-54

4.
Atrial Natriuretic Peptide Genetic Variant rs5065 and Risk for Cardiovascular Disease in the General Community: A 9-Year Follow-Up Study
by Cannone, Valentina
Hypertension (Dallas, Tex. 1979), 2013-11, Vol.62 (5), p.860-865

5.
Genetic loci associated with lipid concentrations and cardiovascular risk factors in the Korean population
by Park, Mi-Hyun
Journal of medical genetics, 2011-01, Vol.48 (1), p.10-15

6.
MicroRNAs Are Involved in End-Organ Damage During Hypertension
by Heggermont, Ward A
Hypertension (Dallas, Tex. 1979), 2012-11, Vol.60 (5), p.1088-1093

7.
Cytochrome P450 1B1 Gene Disruption Minimizes Deoxycorticosterone Acetate-Salt–Induced Hypertension and Associated Cardiac Dysfunction and Renal Damage in Mice
by Jennings, Brett L
Hypertension (Dallas, Tex. 1979), 2012-12, Vol.60 (6), p.1510-1516

8.
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Dis...
by Shah, Svati H., MD, MS, MHS
The American heart journal, 2010, Vol.160 (3), p.371-379.e2

9.
Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders
by Bianchi, Giuseppe
Hypertension (Dallas, Tex. 1979), 2005-03, Vol.45 (3), p.331-340

10.
Angiotensin-Converting Enzyme I/D and α-Adducin Gly460Trp Polymorphisms: From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome
by Li, Yan
Hypertension (Dallas, Tex. 1979), 2007-06, Vol.49 (6), p.1291-1297

11.
Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice
by de la Iglesia, Beatriz
Heart (British Cardiac Society), 2011-03, Vol.97 (6), p.491-499

12.
TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study
by Bielinski, S. J
Diabetologia, 2008-04-24, Vol.51 (6), p.968-970

13.
Rationale and design of the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)
by Eagle, Kim A., MD
The American heart journal, 2009, Vol.157 (2), p.319-326

14.
Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans
by Li, Rongling
American journal of hypertension, 2004, Vol.17 (7), p.560-567

15.
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC): Results from phase I and scientific opportunities in phase II
by Kroner, Barbara L., PhD
The American heart journal, 2011, Vol.162 (4), p.627-632.e1

16.
Y Are Males So Difficult to Understand?: A Case Where “X” Does Not Mark the Spot
by Sampson, Amanda K
Hypertension (Dallas, Tex. 1979), 2012-03, Vol.59 (3), p.525-531

17.

18.
Quantitative Genetic Analysis of the Retinal Vascular Caliber: The Australian Twins Eye Study
by Sun, Cong
Hypertension (Dallas, Tex. 1979), 2009-10, Vol.54 (4), p.788-795

19.
Association of the Complement Factor H Y402H Polymorphism With Cardiovascular Disease Is Dependent Upon Hypertension Status: The ARIC Study
by Volcik, Kelly A
American journal of hypertension, 2008-05, Vol.21 (5), p.533-538

20.
Vascular Functions of NADPH Oxidases
by Brandes, Ralf P
Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.17-21
